SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Two insiders at Entrada Therapeutics (Director Kush Parmar and 10%…

Entrada Therapeutics, Inc. · CLUSTER filed Aug 3, 2026 at 17:32 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 3, 2026 at 17:32 ET

Two insiders at Entrada Therapeutics (Director Kush Parmar and 10% owner 5AM Ventures) sold a combined $1.59M in open-market sales over two days, representing ~0.6% of the company's $264M market cap. This is a significant cluster of selling by a director and a major venture holder, but the dollar amount is modest relative to market cap and the sales are likely part of a pre-arranged plan or liquidity event rather than a bearish signal. The stock has a strong analyst consensus (86% bullish) and recent insider activity includes $1.6M in sales over 30 days, suggesting a pattern of routine selling rather than a new negative development.

  • Director Kush Parmar sold 114,756 shares at $6.93 on 2026-07-30 for $795K
  • 5AM Ventures V, L.P. sold 114,756 shares at $6.93 on 2026-07-30 for $795K
  • Total cluster value: $1.59M, representing ~0.6% of $264M market cap
  • Both insiders also sold 1,718 shares each at $6.85 on 2026-07-31 for ~$11.8K total

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access